Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Soy protein/isoflavones and venlafaxine may help relieve hot flashes in patients
receiving hormone therapy for prostate cancer. It is not yet known whether soy
protein/isoflavones are more effective than venlafaxine when given together or with a placebo
in treating hot flashes.
PURPOSE: This randomized phase III trial is studying soy protein/isoflavones and venlafaxine
to compare how well they work when given together or with a placebo in treating hot flashes
in patients receiving hormone therapy for prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest University Wake Forest University Health Sciences